Health promotion for ultra-Orthodox mothers of children with ADHD
Official title: Non-randomized Controlled Pilot Study of a Health Promotion Program for Mothers of Children in the Ultra-orthodox Community: Examining Feasibility
Run by Hebrew University of Jerusalem · NCT06703242 · Data updated 2026-11-12
This study tests a new support program for ultra-Orthodox mothers of children with ADHD to see if it can help them feel less stressed and improve their overall well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | Women only |
| Enrollment | 32 (estimated) |
| Sponsor | Hebrew University of Jerusalem Academic / other |
| Locations | 1 site (Jerusalem) |
| Status | Recruiting |
| Started | November 24, 2024 |
| Main results expected | January 2025 |
| Study ends | May 2025 |
| Registry record updated | November 27, 2024 |
| Trial ID | NCT06703242 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ultra-Orthodox Jewish mothers with a child aged 6-12 years diagnosed with ADHD.
✕Probably not a fit
Patients who may not benefit include those whose children have other major health conditions in addition to ADHD.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility and effectiveness of a culturally tailored health promotion intervention for ultra-Orthodox Jewish mothers of children diagnosed with ADHD. It involves six weekly teletherapy group sessions aimed at reducing maternal stress, enhancing health, and improving well-being. The intervention focuses on increasing knowledge about ADHD, reducing stigma, and promoting self-care practices among mothers. Participants will complete questionnaires before and after the intervention to assess its impact.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the mental health and well-being of mothers, leading to better outcomes for both mothers and their children with ADHD.
How similar studies have gone: Other studies have shown success with culturally tailored interventions for similar populations, indicating potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * mothers of children with ADHD aged 6- 12 years old * Mothers who identify as ultra-orthodox Jews * Child diagnosis was by a licensed medical professional Exclusion Criteria: * Child medical diagnosis other than ADHD
Where it's running
-
Hebrew University
Jerusalem, Israel Recruiting
Study contacts
- Principal investigator: Adina Maeir, PhD — Hebrew University
- Study coordinator: Jennifer Budman, PhD
- Email: jennifer.budman@mail.huji.ac.il
- Phone: 972 503422600
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ALKS 7290 vs placebo in adults with ADHD
This trial tests whether ALKS 7290 can help adults with ADHD better than a placebo.
-
Unified care and integrated treatments for ADHD with substance use in prison settings
Aimed at people under correctional supervision who have ADHD and substance use disorder, this program tests a coordinated care approach to improve identification and support.
-
Behavioral parent training with optional AI support for children with disruptive behaviors
This trial will test whether adding a 24/7 AI assistant to online group behavioral parent training helps parents manage children aged 5–12 with disruptive behaviors.
-
How the mediodorsal thalamus supports flexible thinking and decision making
This study will test whether the mediodorsal thalamus helps flexible thinking in healthy adults, with implications for people with schizophrenia or ADHD.
-
Nightly external trigeminal nerve stimulation to reduce ADHD symptoms in children with autism
This trial will test whether a small, nightly forehead patch that delivers external trigeminal nerve stimulation can reduce ADHD symptoms in children with autism.
-
Pai.ACT: AI-powered chatbot-assisted ACT for parents of children with neurodevelopmental disorders
This trial tests a chatbot-guided ACT program for Cantonese-speaking parents of young children with neurodevelopmental disorders to see if it helps reduce parenting stress and improves family well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.